Contemporary Neurology 2025

Contemporary Neurology 2025 is organized by Clinical Neurological Society of America (CNSA) and will be held from Jan 18 - 21, 2025 at Hilton Clearwater Beach Resort & Spa, Clearwater Beach, Florida, United States of America.

Statement of Need/Program Overview:
To be more capable of practicing at the current standard of care, neurologists need a better understanding of the pathophysiology, recognition, and treatment of neuromuscular disorders, autonomic dysfunction in movement disorders and peripheral neuropathies, immune system impact on central nervous system disorders, epilepsy management in pregnant people and aged people, stroke management, monoclonal antibody use in Alzheimer disease, concussion management, sleep disorders, headache disorders, and Parkinson disease. Understanding the role of deep brain stimulation in movement disorders is also necessary. Finally, neurologists need to recognize the importance of diversity in education to patient care and develop strategies to address the impact of social factors on our aging population. This educational program aims to explore current and upcoming developments in neurology as well as reduce healthcare inequalities in patient management. At the completion of this program learners will have developed understanding of and skills in managing a spectrum of neurologic conditions, emphasizing shared decisionmaking best practices.

Educational Objectives:
After completing this activity, participants should be better able to:

• Identify newly approved and emerging treatment options for various neurological diseases, including Pompe disease, hATTR amyloidosis, SOD1 amyotrophic lateral sclerosis, adult spinal muscular atrophy, Duchene muscular dystrophy, and myasthenia gravis 
• Describe the rationale of ongoing treatment trials for various neurological diseases, including FSHD, Myotonic Dystrophy, Becker muscular dystrophy, and CIDP.
• Explain the latest diagnostic approaches and treatment options for autonomic failure and dysfunction, including autonomic failure occurring in movement disorders such as Parkinson disease and multiple system atrophy as well as peripheral nerve disorders such as diabetes and autonomic dysfunction in postural tachycardia syndrome.
• Discuss the latest research on the immune system’s role in neurological disorders including updates on the novel CNS demyelinating diseases, MOG antibody disease, and autoimmune encephalitis. 
• Discuss the challenges for managing late-onset epilepsy patients. 
• Discuss the considerations for managing epilepsy in pregnant women. 
• Describe recent advances and emerging tools in stroke prevention, diagnosis, treatment modalities, and rehabilitation strategies.
• Explain new tools for diagnosing Alzheimer disease 
• Discuss the latest research on monoclonal antibodies in the treatment and prevention of Alzheimer disease. 
• Identify recent advances in the diagnosis and treatment of brain tumors. 
• Discuss contemporary methods for diagnosing and managing concussions 
• Compare the advantages and limitations of treatment options for sleep disorders including insomnia, narcolepsy and sleep apnea. 
• Discuss recent advancements in the diagnosis and management of different types of headache disorders. 
• Describe the importance of diversity and inclusion in clinician education and healthcare as it relates to the benefits in patient care. 
• Compare the benefits and risks of using multiple medications with differing mechanisms of action for the treatment of Parkinson disease. 
• Analyze the impact of social factors (e.g., social isolation, access to care, socioeconomic status) and develop strategies to address social and structural inequities that contribute to cognitive decline in aging populations. 
• Review the use of deep brain stimulation (DBS) for the treatment of movement disorders 
• Compare the potential benefits and limitations of traditional DBS compared with new adaptive DBS (aDBS) devices and therapies.